Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Why Risk Mitigation Tools Are A Hard Sell In Pharma-And What Might Change That
George Achilleos is the CEO of NetraMark Holdings Inc. Drug development has a strange economic problem. A pharmaceutical company may be willing to spend tens or even hundreds of millions of dollars advancing a drug into a major clinical…
Adarx Pharma Shares Climb 30% After $446.3 Million Upsized IPO
Adarx Pharmaceuticals Inc., a late-stage developer of gene therapies, jumped 30% after raising $446.3 million in an upsized initial public offering. Shares of the San Diego-based firm, which counts OrbiMed Advisors as a backer, opened at $22.10…
Pharma stock soars 150% on injectables deal with Wegovy maker Novo
The Swedish drug-delivery company agreed to license its PharmaShell technology to Novo Nordisk for up to five development programs targeting obesity, type 2 diabetes and other cardiometabolic conditions. Novo Nordisk will use the technology to…
AI risk raises the bar for outsourced pharma marketing deals
Axios Pro Exclusive Content 51 mins ago…
Is Buying Royalty Pharma Stock a Safer Way to Bet on Revolution Medicines?
Revolution Medicines (RVMD +4.78%) just got some very good news: The FDA gave the company's RASONQUE breakthrough therapy designation. That could help speed the metastatic pancreatic cancer drug to market. But the stock is up 330% over the past…
Kanpur Murder Twist: Rs 40 Lakh Debt, Property Dispute Put Pharma Dealer's Son Under Scanner | Dynamite News
Post Published By: Rishira Jain Updated: 25 September 2026, 3:38 PM IST Kanpur: A shocking twist has emerged in the murder case of Uttar Pradesh pharmaceutical businessman Vineet Manocha, with police claiming that the victim's own son allegedly…
Natco Pharma board approves rights issue to raise up to ₹1,279 crore
Drug maker Natco Pharma on Friday said its board of directors has approved the issuance of equity shares through a rights issue to raise up to ₹1,279.35 crore. According to a regulatory filing, the company will issue up to 1,70,58,082 equity…
Nifty holds 23,000, Sensex up 44 pts; Axis Bank, Asian Paints gain as IT, Pharma drag
Markets were trading in a narrow range around midday on Friday, with the Nifty 50 at 23,051.50, down 11.60 points or 0.05 per cent, and the Sensex at 73,624.77, up 44.23 points or 0.06 per cent, as of 1.58 pm. The indices managed to hold above the…
Royalty Pharma Eyes AI, China Growth While Navigating Biopharma Policy Shifts
How Royalty Pharma Prints Cash Without Biotech's Biggest Risks Royalty Pharma NASDAQ: RPRX executives said the company is monitoring a shifting biopharma policy environment, expanding its artificial-intelligence capabilities and building a presence…
How Chinese biotech is graduating from licensing deals to broader partnerships
Chinese biotech deal making is moving beyond the licensing of individual drug candidates, as the country transforms from a follower to a global innovation leader, according to analysts. The latest transaction underscores that shift. Beijing-based…
CROSSJECT strengthens its governance for the industrial and commercial deployment phase
The Executive Board is expanded to five members: Olivier Lacombe, Didier Morin and Lionel Seltz join Patrick Alexandre and Isabelle Liebschutz A leadership team covering the entire value chain: pharmaceutical development, industrial operations…
Orion Corporation: Acquisition of own shares during week 39, 2026
Orion Corporation: Acquisition of own shares during week 39, 2026 The share buybacks form part of the share buyback programme that Orion Corporation announced on 27 August 2026. The buyback programme runs from 1 September 2026 until no later than…
Viking Therapeutics Soared After Its Latest GLP-1 Data. Is It Too Late to Buy?
Today, a very valuable market -- one heading toward $100 billion by the end of the decade -- is dominated by two pharma giants, Eli Lilly and Novo Nordisk. And this is the weight loss drug market. Lilly and Novo each sell GLP-1 drugs, products that…
The Peptide Boom That Isn't About Your Muscles
Peptides are everywhere lately. Influencers inject them for muscle and recovery, and the Food and Drug Administration could soon allow these products to be sold by compounding pharmacies. While the marketing of these injections to biohackers and…
Sensex gains over 100 pts, Nifty hovers around 23,100
Indian equity markets recovered soon after opening in the red on Friday, extending Thursday's correction, to trade largely flat. The Sensex gained over 100 points, while the Nifty hovered around the 23,100 mark, with Nifty IT emerging as the…
Receive a Daily briefing on Pharma Industry News
Get Started